Nukleus Office Solutions schedules 7th AGM for September 25, 2026

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Nukleus Office Solutions schedules its 7th AGM for September 25, 2026
  • The meeting will start at 11:30 am via video conference or OA/VM
  • Newspaper ads were published on September 1, 2026 in Financial Express and Jansatta
  • The FY26 Annual Report is available electronically for registered shareholders
powered bylight_fuzz_icon
49786354

*this image is generated using AI for illustrative purposes only.

Nukleus Office Solutions has scheduled its 7th Annual General Meeting (AGM) for September 25, 2026. The meeting will commence at 11:30 am and be conducted through Video Conference or Other Audio-Visual Means.

The company published newspaper advertisements in Financial Express and Jansatta on September 1, 2026, pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The AGM will be held in compliance with the Companies Act, 2013, and circulars issued by the Ministry of Corporate Affairs and SEBI. The deemed venue for the meeting is the registered office of the company.

Detail Information
Date September 25, 2026
Time 11:30 am
Mode Video Conference / OA/VM
Notice Ref Reg 30 & 47 of SEBI LODR 2015

Annual Report Access

The Annual Report for FY26, along with the AGM notice, will be sent electronically to members with registered email addresses. Those without registered emails will receive a letter containing a web link and QR code. The documents are also available on the company website, BSE Limited, and Bigshare Services Private Limited.

Historical Stock Returns for Nukleus Office solutions

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-1.83%0.0%0.0%0.0%

What specific financial performance metrics or strategic initiatives are expected to be highlighted in the FY26 Annual Report presented at the AGM?

How might the decision to conduct the AGM via Video Conference impact shareholder engagement levels compared to previous in-person meetings?

Are there any proposed changes to the board of directors or executive compensation packages that shareholders will be voting on during this meeting?

Nukleus Office solutions
View Company Insights
View All News
like16
dislike

Nukleus Office Solutions approves 201,600 ESOPs for employees

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Nukleus Office Solutions board approved ESOP Scheme-I 2026 on Aug 29
  • Total pool of 201,600 options allocated to eligible employees
  • Options vest after one year and are exercisable within two years
  • Shareholder approval required via Special Resolution for implementation
powered bylight_fuzz_icon
49103564

*this image is generated using AI for illustrative purposes only.

Nukleus Office Solutions Limited approved its Employee Stock Option Scheme-I 2026 during a board meeting on August 29, 2026. The scheme grants 201,600 options to eligible employees to attract and retain talent.

The Board of Directors considered the recommendation of the Nomination and Remuneration Committee before approving the plan. The move aligns employee interests with the company's long-term growth. Implementation is subject to shareholder approval via a Special Resolution and other regulatory consents.

Key Terms of the ESOP Scheme

The board approved specific terms for the grant, vesting, and exercise of the options under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Term Details
Total Options 201,600 Employee Stock Options
Vesting Period One year from date of Grant
Exercise Period Two years from date of Grant
Pricing Determined per applicable laws at time of Grant

Options vest upon completion of one year from the date of grant, subject to continued employment and performance-linked conditions. Vested options must be exercised within two years from the date of grant. The exercise price will be determined according to prevailing laws and scheme terms at the time of grant.

Next Steps

The board authorized the convening of a General Meeting to seek shareholder consent for the scheme. The draft notice and explanatory statement were also approved. Mr. Vinay Rathore, Company Secretary and Compliance Officer, was authorized to handle necessary filings with regulatory authorities.

Historical Stock Returns for Nukleus Office solutions

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-1.83%0.0%0.0%0.0%

How might the dilution from 201,600 new options impact existing shareholders' earnings per share once the scheme is fully exercised?

What specific performance-linked conditions have been set for vesting, and how do they align with Nukleus Office Solutions' strategic growth targets for 2026-2028?

Will the upcoming General Meeting see any significant dissent from shareholders regarding the valuation methodology used for the exercise price?

Nukleus Office solutions
View Company Insights
View All News
like19
dislike

More News on Nukleus Office solutions

1 Year Returns:0.00%